Public Health DR Congo

DR Congo Maternal Immunisation Public Health Report

Updated Reviewed by Vidhi Upadhyay

DR Congo Maternal Immunisation Public Health Report: Need and Coverage, Demographic and Geographic Distribution, Risk Factors, Screening and Diagnosis, Treatment Coverage, Programmes, Gaps and Outlook

Public Health Dashboard · published data

Maternal Immunisation in DR Congo: key statistics

DR Congo

Who pays for health in DR Congo

Only published figures are shown here, with their year and source. The full report keeps reported cases, survey estimates and modelled estimates apart, and names the data gaps.

Buy the full report

Report snapshot

DR Congo Maternal Immunisation Public Health Report at a glance
TopicMaternal Immunisation
PlaceDR Congo
DTP3 vaccine (latest)65% of 1-year-olds (2025)Source: WHO Global Health Observatory, DTP3 vaccine (% of 1-year-olds). Retrieved 20 Nov 2026.
Report sections16 (table of contents)
Active clinical trials2 in DR CongoSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in DR Congo. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

DR Congo Maternal Immunisation: Overview and Epidemiological Profile

Maternal immunisation vaccinates women during pregnancy to protect both the mother and her newborn baby in the first months of life. This report covers tetanus vaccination, influenza vaccination, pertussis vaccination and RSV vaccination.

Burden: Prevalence, Incidence and Mortality

The report sets out the scale of need for maternal immunisation in DR Congo: who needs it, how many are reached and the health problems it addresses, using DTP3 Coverage, Measles Second-Dose Coverage, Zero-Dose Children, Vaccine-Preventable Disease Cases and Dropout Between Doses.

Demographic Distribution: Age, Gender and Vulnerable Population Groups

Need and coverage are broken down by age (infants under 1 year, children 1–4 years, children 5–14 years, adolescents 15–19 years and adults), gender and income, with a focus on zero-dose children, children in urban slums, children in conflict areas, remote rural communities, pregnant women and older adults.

Geographical Distribution: State, District, Urban and Rural Segmentation

Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.

Risk Factors and Social Determinants of Health

Main risk factors include distance to health services, conflict and insecurity, vaccine hesitancy and misinformation, poverty and low maternal education, weak supply chains and health worker shortages. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.

Awareness and Screening Coverage

The report reviews awareness and uptake of maternal immunisation, and how people in need are found, through vaccination registers and home-based records, disease surveillance, coverage surveys and tracing missed children, by group and by area.

Diagnosis Rates and Undiagnosed Burden

It compares the number of people who need maternal immunisation with the number reached, to show the coverage gap and which groups are missed.

Treatment, Prevention and Coverage

Treatment and prevention covered include vaccination in antenatal care, health worker recommendation, supply through antenatal clinics and safety monitoring, with how widely each is delivered and how well it is sustained.

Health Outcomes and Complications

Health outcomes covered include outbreaks of vaccine-preventable disease, child deaths, disability from preventable disease and strain on health services, and what is known about the effect of maternal immunisation on them.

Healthcare Infrastructure and Accessibility

The report looks at immunisation clinics and outreach posts, cold chain equipment, vaccinators and community mobilisers and vaccine supply chains, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.

Economic and Socioeconomic Burden

Maternal Immunisation in DR Congo: health cover, spending and research

DR Congo scores 41 out of 100 on the WHO universal health coverage index (2023).⁠[1] People pay 38.0% of all health spending out of their own pockets (2023).⁠[2] Money from abroad pays for 37.0% of health spending (2023).⁠[3] ClinicalTrials.gov lists 2 studies on Maternal Immunisation that are recruiting, active or about to start in DR Congo.⁠[4] DTP3 vaccine: 65% of 1-year-olds in 2025, the latest WHO figure for DR Congo.⁠[5]

[1] WHO Global Health Observatory, Universal health coverage index (index (0–100)). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Out-of-pocket spending (% of health spending). Retrieved 19 Nov 2026.

[3] World Bank Open Data, Health spending from abroad (% of health spending). Retrieved 20 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in DR Congo. Retrieved 12 Nov 2026.

[5] WHO Global Health Observatory, DTP3 vaccine (% of 1-year-olds). Retrieved 20 Nov 2026.

It describes what maternal immunisation costs to deliver, who pays for it and the costs that fall on households, including funding from government, donors and NGOs.

Government Initiatives and Public Health Interventions

Worldwide guidance and funding for maternal immunisation include WHO Immunization Agenda 2030, Gavi, the Vaccine Alliance, UNICEF Supply Division and Global Polio Eradication Initiative. The report reviews national programmes, donor and NGO funding, and what is known about their impact.

Historical Trends and Comparative Analysis

Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.

Healthcare Gaps and Unmet Needs

The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.

Future Burden and Public Health Outlook

It looks ahead at future need for maternal immunisation, the resources it will require and the areas most at risk of falling behind.

Key Findings and Strategic Recommendations

The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), Demographic and Health Surveys (DHS), WHO Vaccine-Preventable Disease Surveillance and National Immunisation Programme Data. Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Maternal Immunisation Public Health Report right now, from free public sources.

Clinical trials

2 active trials in DR Congo

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Pfizer Inc. 6 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Maternal Immunisation Public Health Report in context

DR Congo compared

  • DTP3 vaccine: 65% of 1-year-olds (2025). World: 85% of 1-year-olds (2025). 16th highest of the 17 countries we cover in Africa.[1]
  • Health spending per person: 23 US$ per person (2023). World: 1,317 US$ per person (2023). 16th highest of the 17 countries we cover in Africa.[2]
  • Doctors: 0.21 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 9th highest of the 17 countries we cover in Africa.[3]

[1] WHO Global Health Observatory, DTP3 vaccine (% of 1-year-olds). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

What is maternal immunisation?
Maternal immunisation vaccinates women during pregnancy to protect both the mother and her newborn baby in the first months of life. This report covers tetanus vaccination, influenza vaccination, pertussis vaccination and RSV vaccination.
What does the report on maternal immunisation in DR Congo cover?
The report has 16 sections: overview and epidemiological profile; burden; demographic distribution; geographical distribution; risk factors and social determinants of health; awareness and screening coverage; diagnosis rates and undiagnosed burden; treatment, prevention and coverage; health outcomes and complications; healthcare infrastructure and accessibility; economic and socioeconomic burden; government initiatives and public health interventions; historical trends and comparative analysis; healthcare gaps and unmet needs; future burden and public health outlook; key findings and strategic recommendations.
How good is health coverage in DR Congo?
DR Congo scores 41 out of 100 on the WHO universal health coverage index (2023). Source: WHO Global Health Observatory, Universal health coverage index. Retrieved 19 Nov 2026.
How much of health spending do people pay themselves in DR Congo?
People pay 38.0% of all health spending out of their own pockets (2023). Source: World Bank Open Data, Out-of-pocket spending. Retrieved 19 Nov 2026.
How many clinical trials on maternal immunisation are running in DR Congo?
2 studies are recruiting, active or about to start in DR Congo, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in DR Congo. Retrieved 12 Nov 2026.
What does WHO report for DR Congo?
DTP3 vaccine: 65% of 1-year-olds in 2025, the latest WHO figure. Source: WHO Global Health Observatory, DTP3 vaccine (% of 1-year-olds). Retrieved 20 Nov 2026.
How many people in DR Congo are 65 or older?
3.1% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 19 Nov 2026.
Back to Catalogue

Related Public Health reports in DR Congo

See all

Related on vaccines and maternal

See the topic